A Pharmaceutical composition for treating Diabetes and Metabolic Disorders Combination

摘要

A pharmaceutical composition for administering to a patient suffering from diabetes to other metabolic diseases, the composition comprises: a) an enhanced activated form of an antibody against a human insulin receptor, and b) an enhanced activated form of an antibody against NO- endothelial synthase Claim 11: The pharmaceutical composition of claim 1, characterized in that said human insulin receptor consists of a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4 , SEQ ID No. 5, SEQ ID No. 6, SEQ ID No. 7, SEQ ID No. 8, SEQ ID No. 9, SEQ ID No. 10, SEQ ID No. 11, SEQ ID No. 12,SEQ ID No. 13, SEQ ID No. 14. Claim 12: The pharmaceutical composition of claim 1, characterized in that said endothelial NO-synthase consists of a sequence provided in SEQ. ID No. 15, SEQ ID No. 16, SEQ ID No. 17, SEQ ID No. 18, SEQ ID No. 19, SEQ ID No. 20, SEQ ID No. 21, SEQ ID No. 22.